The latest version of the PD-MitoQUANT newsletter was published on January 27, 2021. In it, partners share stories from the Parkinson’s UK Virtual Research Conference. Meet Dr Alexander Kel, Founder and Chief Scientific Officer (CSO) of geneXplain GmbH. And much more! Visit https://www.pdmitoquant.eu/2021/01/read-all-our-latest-news/
Learn more about the project on the PD-MitoQUANT website.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.
The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.